Multimodality Imaging of Pancreatic Cancer—Computed Tomography, Magnetic Resonance Imaging, and Positron Emission Tomography
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Pancreatic adenocarcinoma continues to have a dismal prognosis, with curative surgery (resection with negative margins) possible in only a small percentage of patients. Not only does radiological imaging play a major role in diagnosing the primary lesion at presentation, but it is also crucial for staging of locoregional disease and distant metastases, both of which are critical for selecting appropriate candidates for surgery. Over the last 2 decades, computed tomography has become the dominant imaging modality for both the diagnosis and staging of pancreatic cancer, with advances in multidetector computed tomography technology improving the ability to identify small tumors and demonstrate subtle degrees of vascular involvement by tumor. However, magnetic resonance imaging and positron emission tomography are now playing an increasing role in pancreatic cancer imaging. These 3 imaging modalities each have specific strengths and benefits and should be used in a complementary fashion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kauhanen, S. P., Komar, G., Seppänen, M. P., Dean, K. I., Minn, H. R., Kajander, S. A., Rinta-Kiikka, I., Alanen, K., Borra, R. J., Puolakkainen, P. A., et al. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b2fafa · Cited by 317 · cited 3×
“The sensitivity and specificity of PET-CT for local lymph node metastases may be as low as 46% and 63%, respectively.(2,23) The poor resolution of PET for lesions less than 1 cm undoubtedly contributes to this poor performance.”
BackgroundMagnetic Resonance Imaging of Adenocarcinoma of the Pancreas
Vachiranubhap, B., Kim, Y. H., Balci, N. C., & Semelka, R. C. (2009) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0b013e3181b48392 · Cited by 83 · cited 8×
“Accounting for more than 95% of all pancreatic exocrine malignancies, pancreatic ductal adenocarcinoma is known to have a dismal prognosis, with less than 5% survival at 5 years.(1) In those few cases where curative treatment is a possibility, resectional surgery is the only definitive option.”
BackgroundInfluential
Cited by
Challenges in diagnosis of pancreatic cancer
Zhang, L., Sanagapalli, S., & Stoita, A. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i19.2047 · Cited by 588
Imaging diagnosis of pancreatic cancer: A state-of-the-art review
Lee, E. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i24.7864 · Cited by 401
Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review
Elbanna, K. Y., Jang, H.-J., & Kim, T. K. (2020) · Insights into Imaging · doi:10.1186/s13244-020-00861-y · Cited by 162
The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia
Eloubeidi, M. A., Decker, G. A., Chandrasekhara, V., Chathadi, K. V., Early, D. S., Evans, J. A., Fanelli, R. D., Fisher, D. A., Foley, K., Hwang, J. H., et al. (2016) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.09.009 · Cited by 146
Artificial intelligence in pancreatic cancer
Huang, B., Huang, H., Zhang, S., Zhang, D., Shi, Q., Liu, J., & Guo, J. (2022) · Theranostics · doi:10.7150/thno.77949 · Cited by 142
“With the use of multiplanar reformations, 3D techniques, and spatial and temporal resolution improvement, CT has achieved high sensitivity (96%) in tumor identification [18,97].”
Method
Metadata
- Authors
- Raman, S. P., Horton, K. M., & Fishman, E. K.
- Venue
- The Cancer Journal
- Published
- 2012-11
- Volume
- 18
- Issue
- 6
- Pages
- 511-522
- ISSN
- 1528-9117 (ISSN-L)
- OpenAlex
- W2010393002
- Cited by
- 151
- References
- 2
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multimodality Imaging of Pancreatic Cancer—Computed Tomography, Magnetic Resonance Imaging, and Positron Emission Tomography. https://app.cochat.ai/papers/10.1097/ppo.0b013e318274a461
- The paper
- Raman, S. P., Horton, K. M., & Fishman, E. K. (2012). Multimodality Imaging of Pancreatic Cancer—Computed Tomography, Magnetic Resonance Imaging, and Positron Emission Tomography. The Cancer Journal. https://doi.org/10.1097/ppo.0b013e318274a461
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.